TMDX
TransMedics Group, Inc. · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -30.0% ·
Aktienfluss -10.8% ·
neue Nettopositionen -20.0%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | -3 | 25.87M | $1.72B | +11 | −13 |
| Q1 2026 | 110 | -2 | 27.24M | $2.71B | +6 | −9 |
| Q4 2025 | 113 | -2 | 29.10M | $3.52B | +1 | −2 |
| Q3 2025 | 21 | +2 | 20.81M | $2.34B | +2 | −1 |
| Q2 2025 | 17 | +3 | 18.14M | $2.43B | +3 | — |
| Q1 2025 | 11 | -1 | 3.86M | $259.47M | +2 | −3 |
| Q4 2024 | 12 | +2 | 3.62M | $225.65M | +3 | −1 |
| Q3 2024 | 9 | -4 | 2.19M | $344.12M | — | −4 |
| Q2 2024 | 13 | — | 2.46M | $370.15M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passiv) | 763.79K | +1.3% | $119.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passiv) | 763.79K | +1.3% | $119.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Norges Bank ✦ (passiv) | 358.08K | +32.7% | $56.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 303.77K | -3.4% | $47.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 303.77K | -3.4% | $47.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 303.77K | -3.4% | $47.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 303.77K | -3.4% | $47.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 293.47K | -11.2% | $46.08M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 293.47K | -11.2% | $46.08M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 234.89K | -8.8% | $36.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 234.89K | -8.8% | $36.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 234.89K | -8.8% | $36.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 234.89K | -8.8% | $36.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Millennium Management ✦ | 111.84K | +49.9% | $17.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 111.80K | -15.2% | $17.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 9.17K | +204.1% | $1.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 9.17K | +204.1% | $1.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 9.17K | +204.1% | $1.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 4.87K | -78.0% | $764,904 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| D. E. Shaw & Co. | $31.67M | war 0.0% |
| Citadel Advisors | $11.77M | war 0.0% |
| Marshall Wace | $1.42M | war 0.0% |
| Gotham Asset Management | $300,186 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 412 Inhaber, 36.17M Anteile, $3.51B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.